Jubilant Pharmova Limited (JUBLPHARMA) Share Analysis
NSE · Healthcare · Pharmaceuticals
Jubilant Pharmova Limited (NSE: JUBLPHARMA) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 21 Sep 2026, the share price was ₹1,065.00, market capitalisation ₹16,972 Cr, P/E 43.7, ROE 6.53%.
Get the AI verdict on JUBLPHARMA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
JUBLPHARMA price and valuation
- Share price
- ₹1,065.00
- Market cap
- ₹16,972 Cr
- P/E ratio
- 43.7
- P/B ratio
- 2.39
- EPS
- ₹22.11
- Book value per share
- ₹445.00
- Dividend yield
- 0.47%
JUBLPHARMA profitability and growth
- ROE
- 6.53%
- ROCE
- 8.99%
- Debt to equity
- 0.51
- Revenue growth (3 yr)
- 10%
- Revenue growth (5 yr)
- 6%
- Profit growth (3 yr)
- 47%
- Profit growth (5 yr)
- -13%
JUBLPHARMA 52-week range
- 52-week high
- ₹1,184.80
- 52-week low
- ₹786.05
- Face value
- ₹1.00
JUBLPHARMA shareholding pattern
- Promoters
- 47.67%
- FIIs
- 15.87%
- DIIs
- 12.4%
- Public
- 23.5%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.